Literature DB >> 10619434

CD46 is a cellular receptor for human herpesvirus 6.

F Santoro1, P E Kennedy, G Locatelli, M S Malnati, E A Berger, P Lusso.   

Abstract

Human herpesvirus 6 (HHV-6) is the etiologic agent of exanthema subitum, causes opportunistic infections in immunocompromised patients, and has been implicated in multiple sclerosis and in the progression of AIDS. Here, we show that the two major HHV-6 subgroups (A and B) use human CD46 as a cellular receptor. Downregulation of surface CD46 was documented during the course of HHV-6 infection. Both acute infection and cell fusion mediated by HHV-6 were specifically inhibited by a monoclonal antibody to CD46; fusion was also blocked by soluble CD46. Nonhuman cells that were resistant to HHV-6 fusion and entry became susceptible upon expression of recombinant human CD46. The use of a ubiquitous immunoregulatory receptor opens novel perspectives for understanding the tropism and pathogenicity of HHV-6.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619434     DOI: 10.1016/s0092-8674(00)81678-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  160 in total

Review 1.  Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry.

Authors:  D Shukla; P G Spear
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Viral gene expression patterns in human herpesvirus 6B-infected T cells.

Authors:  Bodil Øster; Per Höllsberg
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Adenovirus type 11 uses CD46 as a cellular receptor.

Authors:  Anna Segerman; John P Atkinson; Marko Marttila; Veronica Dennerquist; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites.

Authors:  Wim P Burmeister; Delphine Guilligay; Stephen Cusack; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.

Authors:  Akiko Kawabata; Hiroko Oyaizu; Takahiro Maeki; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

6.  Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle.

Authors:  Hiroko Oyaizu; Huamin Tang; Megumi Ota; Nobuyuki Takenaka; Keiichi Ozono; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

7.  gp96 Is Critical for both Human Herpesvirus 6A (HHV-6A) and HHV-6B Infections.

Authors:  Jingjing Ma; Junli Jia; Xuefeng Jiang; Mengyuan Xu; Jinfeng Guo; Tian Tang; Xianyi Xu; Zhisheng Wu; Benshun Hu; Kun Yao; Lingyun Li; Huamin Tang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

8.  Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.

Authors:  Armin Rashidi; Maryam Ebadi; Bassil Said; Qing Cao; Ryan Shanley; Julie Curtsinger; Nelli Bejanyan; Erica D Warlick; Jaime S Green; Claudio G Brunstein; Jeffrey S Miller; Daniel J Weisdorf
Journal:  Am J Hematol       Date:  2018-05-14       Impact factor: 10.047

Review 9.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

10.  CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.

Authors:  Milena Iacobelli-Martinez; Ronald R Nepomuceno; Jodi Connolly; Glen R Nemerow
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.